Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2019 | Treatment of aggressive NHL in frail patients: cardiac comorbidities and advanced age

Pieternella Lugtenburg • 20 Jun 2019
ICML 2019
Lymphoma Non-Hodgkin Lymphoma

Pieternella Lugtenburg, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, discusses the treatment of aggressive non-Hodgkin lymphoma in frail patients, particularly due to cardiac comorbidities and advanced age. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

More from Pieternella Lugtenburg

1:52
Rituximab maintenance shows no advantage over observation in DLBCL
Pieternella Lugtenburg • 20 Jun 2019
2:36
Dutch HOVON lymphoma study group update
Pieternella Lugtenburg • 20 Jun 2019

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals